Knecht-Gurwin Klaudia, Stefaniak Aleksandra A, Chlebicka Iwona, Szepietowski Jacek C
Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Chałubińskiego 1, 50-368 Wrocław, Poland.
Biomedicines. 2024 Aug 6;12(8):1769. doi: 10.3390/biomedicines12081769.
Basal cell carcinoma (BCC) arising within scar tissue is a rare but clinically significant phenomenon. This comprehensive review aims to provide a succinct overview of the current state of knowledge regarding the etiological factors, pathogenesis, clinical presentation, and management of BCC. This study constitutes a literature review pertaining to BCC, with a particular emphasis on BCC developing within scar tissue. It also provides a clinical case presentation of a patient who had developed BCC in a BCG post-vaccination scar and a review of analogous findings available in the existing literature. Despite the fact that an array of mechanisms play a role in injury-related BCC growth, the main mechanism remains ambiguous and yet to be elucidated. The review also includes a detailed description of the various therapeutic options available for BCC, ranging from surgical interventions to novel pharmacological treatments. By examining these intersections, the review seeks to elucidate the potential mechanisms, identify risk factors, and suggest considerations for clinical practice. The findings underscore the importance of vigilant dermatological assessment in patients with scar tissue and those recently vaccinated, aiming to improve early detection and optimize management strategies for BCC.
发生于瘢痕组织内的基底细胞癌(BCC)是一种罕见但具有临床意义的现象。本综述旨在简要概述目前关于BCC病因、发病机制、临床表现及治疗的知识现状。本研究为关于BCC的文献综述,特别关注在瘢痕组织内发生的BCC。文中还提供了一例在卡介苗接种后瘢痕处发生BCC患者的临床病例报告,以及对现有文献中类似发现的综述。尽管一系列机制在与损伤相关的BCC生长中起作用,但主要机制仍不明确且有待阐明。该综述还详细描述了BCC可用的各种治疗选择,从手术干预到新型药物治疗。通过审视这些交叉点,本综述旨在阐明潜在机制、识别危险因素并为临床实践提出注意事项。研究结果强调了对瘢痕组织患者及近期接种疫苗者进行警惕的皮肤科评估的重要性,旨在改善BCC的早期检测并优化管理策略。